165 related articles for article (PubMed ID: 10164796)
1. Changing the rules: coverage of nonprescription drugs.
Navarro RP
Med Interface; 1997 Feb; 10(2):84-6. PubMed ID: 10164796
[No Abstract] [Full Text] [Related]
2. Over-the-counter drugs as a new managed care benefit.
Scheur BS; Aaron RM
Med Interface; 1997 Feb; 10(2):88-94. PubMed ID: 10164797
[TBL] [Abstract][Full Text] [Related]
3. Perspectives. Drug formularies pose legal threat to providers.
Moskowitz DB
Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
[No Abstract] [Full Text] [Related]
4. Unraveling the effects of tier-copayment drug benefit designs.
Curtiss FR
J Manag Care Pharm; 2003; 9(2):177-8. PubMed ID: 14613348
[No Abstract] [Full Text] [Related]
5. PBMs' rebate income threatened by lawsuits and move to generics.
Sipkoff M
Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
[No Abstract] [Full Text] [Related]
6. Perspectives. Will we try to manage care again? This time, for drugs?
Clemmitt M
Med Health; 2000 Jun; 54(25):suppl 1-4. PubMed ID: 11009923
[No Abstract] [Full Text] [Related]
7. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange.
Burkhart CG
J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740
[No Abstract] [Full Text] [Related]
8. Getting serious about generics.
Sipkoff M
Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
[No Abstract] [Full Text] [Related]
9. The response to health care reform by the pharmaceutical industry.
Krulwich AS
Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
[No Abstract] [Full Text] [Related]
10. Datawatch. Rx coverage and consumer ads: a costly combo.
Bus Health; 1998 Oct; 16(10):68. PubMed ID: 10185119
[No Abstract] [Full Text] [Related]
11. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
12. Economics of self-medication: theory and evidence.
Chang FR; Trivedi PK
Health Econ; 2003 Sep; 12(9):721-39. PubMed ID: 12950092
[TBL] [Abstract][Full Text] [Related]
13. Working with PBMs (pharmacy benefit managers).
Peterson C
Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477
[No Abstract] [Full Text] [Related]
14. The MDA's prescription coverage and generic drugs.
Stafford E
J Mich Dent Assoc; 2010 May; 92(5):18. PubMed ID: 20536070
[No Abstract] [Full Text] [Related]
15. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
MacEachern L
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
[TBL] [Abstract][Full Text] [Related]
16. [Medication supply of privately insured patients in 2010].
Wild F
Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
[No Abstract] [Full Text] [Related]
17. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
Liow K; Barkley GL; Pollard JR; Harden CL; Bazil CW;
Neurology; 2007 Apr; 68(16):1249-50. PubMed ID: 17438213
[No Abstract] [Full Text] [Related]
18. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
19. Legislative challenges facing managed care pharmacy.
Epstein L
Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
[No Abstract] [Full Text] [Related]
20. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
Navarro RP
Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
